<p>默克公司（NYSE:MRK - 获取免费报告）在周四收到了异常大量的期权交易。交易者购买了 177,669 份看跌期权。这比平均交易量 40,313 份看跌期权增加了约 341%。</p>
<p>获取 <strong>默克公司</strong> 的提醒：</p>
<h2>默克公司股价下跌 1.5%</h2>
<ul>
<li>默克：购买此跌幅的 4 个不容错过的理由</li>
</ul>
<p>周四，MRK 股票下跌 1.32 美元，报 84.35 美元。该股票的交易量为 20,375,205 股，而其平均交易量为 14,421,404 股。公司的 50 日移动平均价格为 97.82 美元，200 日移动平均价格为 105.65 美元。默克公司的 1 年最低价为 84.31 美元，1 年最高价为 134.63 美元。公司的债务与股本比率为 0.79，流动比率为 1.36，速动比率为 1.15。该公司的市值为 2133.7 亿美元，市盈率为 12.53，市盈增长比率为 0.83，贝塔值为 0.38。</p>
<p>默克公司（NYSE:MRK - 获取免费报告）上一次发布季度财报是在 2 月 4 日，报告显示该季度每股收益为 1.72 美元，低于市场共识预期的 1.85 美元（差 0.13 美元）。该季度的收入为 156.2 亿美元，而分析师预期为 155.1 亿美元。默克公司的股本回报率为 45.35%，净利润率为 26.67%。该公司的收入同比增长 6.8%。去年同期，该公司每股收益为 0.03 美元。分析师预计默克公司今年每股收益将达到 9.01 美元。</p>
<ul>
<li>Moderna 股价因 H5N1 新闻飙升——投资者接下来该怎么办？</li>
</ul>
<p>默克公司宣布其董事会于 1 月 28 日授权了一项股票回购计划，授权公司回购 100 亿美元的流通股。该回购授权允许公司通过公开市场购买最多 4.1% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>默克公司分红公告</h2>
<p>该公司最近宣布了一项季度分红，将于 4 月 7 日支付。3 月 17 日的登记投资者将获得 0.81 美元的分红。这相当于年化 3.24 美元的分红，收益率为 3.84%。除息日为 3 月 17 日。默克公司的分红支付比率（DPR）为 48.14%。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>MarketBeat 周回顾 – 11/4 - 11/8</li>
</ul>
<p>几位研究分析师最近对该股票发表了看法。大和证券在 11 月 11 日的研究报告中将默克公司的股票评级从 “强力买入” 下调至 “持有”。TD 证券将默克公司的评级从 “买入” 下调至 “持有”，并将其目标价从 121.00 美元下调至 100.00 美元。瑞银集团在 1 月 8 日的研究报告中将默克公司的目标价从 125.00 美元下调至 120.00 美元，并对该股票给予 “买入” 评级。摩根士丹利在 2 月 5 日的研究报告中将默克公司的目标价从 113.00 美元下调至 106.00 美元，并对该公司给予 “同等权重” 评级。最后，BMO 资本市场在 2 月 5 日的报告中将默克公司的目标价从 105.00 美元下调至 96.00 美元，并对该公司给予 “市场表现” 评级。一位股票研究分析师对该股票给予了卖出评级，十位分析师给予了持有评级，九位给予了买入评级，三位给予了强力买入评级。根据 MarketBeat 的数据，默克公司目前的共识评级为 “适度买入”，平均目标价为 117.06 美元。</p>
<p><strong>查看我们关于 MRK 的最新报告</strong></p>
<h2>内部人士下注</h2>
<p>在其他新闻中，董事 Inge G. Thulin 于 2 月 6 日的交易中购买了 2,833 股公司的股票。该股票的平均购买成本为每股 88.25 美元，总价值为 250,012.25 美元。收购完成后，该董事现在拥有 2,933 股公司的股票，价值约为 258,837.25 美元。这代表其持股增加了 2,833.00%。该交易已在证券交易委员会的法律文件中披露，可以通过 SEC 网站访问。此外，内部人士 Cristal N. Downing 在 2 月 6 日的交易中出售了 2,361 股公司的股票。该股票的平均售价为 88.76 美元，总价值为 209,562.36 美元。交易完成后，该内部人士现在直接拥有 7,085 股公司股票，价值为 628,864.60 美元。该交易代表其持股减少了 24.99%。该销售的披露信息可以在此找到。公司内部人士持有公司股票的 0.09%。</p>
<h2>机构投资者对默克公司的看法</h2>
<p>最近，一些机构投资者和对冲基金买卖了该股票的股份。E&amp;G Advisors LP 在第三季度将其在默克公司的持股比例提高了 0.7%。E&amp;G Advisors LP 现在拥有 14,698 股该公司的股票，价值 1,669,000 美元，此前在上个季度又购买了 100 股。马萨诸塞州财富管理公司在第三季度将其在默克公司的股份增加了 0.4%。马萨诸塞州财富管理公司现在拥有 22,474 股该公司的股票，价值 2,552,000 美元，此前在此期间又购买了 100 股。Shayne &amp; Jacobs LLC 在第三季度将其在默克公司的持股提高了 1.8%。Shayne &amp; Jacobs LLC 现在拥有 5,611 股该公司的股票，价值 637,000 美元，此前在上个季度又购买了 100 股。Alan B Lancz &amp; Associates Inc.在第三季度将其在默克公司的股份提高了 0.7%。Alan B Lancz &amp; Associates Inc.现在拥有 13,834 股该公司的股票，价值 1,571,000 美元，此前在此期间又购买了 100 股。最后，First Bank &amp; Trust 在第三季度将其在默克公司的股份提高了 1.1%。First Bank &amp; Trust 现在拥有 8,995 股该公司的股票，价值 1,021,000 美元，此前在此期间又购买了 101 股。76.07% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>默克公司简介</h2>
<p>(获取免费报告)</p>
<p>默克公司是一家医疗保健公司，提供通过处方药、疫苗、生物治疗、动物健康和消费者护理产品的健康解决方案。它通过以下几个部门运营：制药、动物健康和其他。制药部门包括人类健康药品和疫苗产品。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过默克公司。</li>
<li>学习技术分析技能，掌握股市。</li>
<li>Upstart 的上升趋势刚刚开始：是时候加仓了。</li>
<li>投资者需要知道的击败市场的信息。</li>
<li>Archer Aviation 获得黑石投资——ACHR 的下一步是什么？</li>
<li>如何投资蓝筹股。</li>
<li>巴菲特增持西方石油——坚持他的投资策略。</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资$1,000 吗？</h2>
<p>在你进行下一笔交易之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。</p>
<p>我们的团队已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而且没有一只大名鼎鼎的股票在名单上。</p>
<p>他们认为这五只股票是投资者现在应该购买的五家最佳公司……</p>
<p>查看这五只股票</p>
<h2>你现在应该投资$1,000 在默克公司吗？</h2>
<p>在你考虑默克公司之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而默克公司不在名单上。</p>
<p>虽然默克公司目前在分析师中有 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

默克

<p>默克公司（NYSE:MRK）经历了显著的看跌期权交易激增，共购买了 177,669 份期权，较平均日交易量增加了 341%。股价下跌了 1.5%，至 84.35 美元，交易量超过 2000 万股。默克最近的季度财报显示，收入为 156.2 亿美元，略高于预期，但每股收益未能达到预期。公司还宣布了一项 100 亿美元的股票回购计划和每季度 0.81 美元的股息，反映出对其股票价值的信心</p>

<p>Merck &amp; Co., Inc. (NYSE:MRK - Get Free Report) was the recipient of unusually large options trading on Thursday. Traders acquired 177,669 put options on the company. This represents an increase of approximately 341% compared to the average volume of 40,313 put options.</p>
<div class="lb-trans"><p>默克公司（NYSE:MRK - 获取免费报告）在周四收到了异常大量的期权交易。交易者购买了 177,669 份看跌期权。这比平均交易量 40,313 份看跌期权增加了约 341%。</p>
</div><p>Get <strong>Merck &amp; Co., Inc.</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>默克公司</strong> 的提醒：</p>
</div><h2>Merck &amp; Co., Inc. Trading Down 1.5 %</h2>
<div class="lb-trans"><h2>默克公司股价下跌 1.5%</h2>
</div><ul>
<li>Merck: 4 No-Brainer Reasons to Buy This Dip</li>
</ul>
<div class="lb-trans"><ul>
<li>默克：购买此跌幅的 4 个不容错过的理由</li>
</ul>
</div><p>Shares of MRK stock traded down $1.32 on Thursday, hitting $84.35. The stock had a trading volume of 20,375,205 shares, compared to its average volume of 14,421,404. The company's 50 day moving average price is $97.82 and its 200-day moving average price is $105.65. Merck &amp; Co., Inc. has a 1 year low of $84.31 and a 1 year high of $134.63. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.36 and a quick ratio of 1.15. The firm has a market capitalization of $213.37 billion, a P/E ratio of 12.53, a P/E/G ratio of 0.83 and a beta of 0.38.</p>
<div class="lb-trans"><p>周四，MRK 股票下跌 1.32 美元，报 84.35 美元。该股票的交易量为 20,375,205 股，而其平均交易量为 14,421,404 股。公司的 50 日移动平均价格为 97.82 美元，200 日移动平均价格为 105.65 美元。默克公司的 1 年最低价为 84.31 美元，1 年最高价为 134.63 美元。公司的债务与股本比率为 0.79，流动比率为 1.36，速动比率为 1.15。该公司的市值为 2133.7 亿美元，市盈率为 12.53，市盈增长比率为 0.83，贝塔值为 0.38。</p>
</div><p>Merck &amp; Co., Inc. (NYSE:MRK - Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $1.72 EPS for the quarter, missing the consensus estimate of $1.85 by ($0.13). The business had revenue of $15.62 billion during the quarter, compared to analyst estimates of $15.51 billion. Merck &amp; Co., Inc. had a return on equity of 45.35% and a net margin of 26.67%. The business's revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.03 EPS. Analysts anticipate that Merck &amp; Co., Inc. will post 9.01 earnings per share for the current year.</p>
<div class="lb-trans"><p>默克公司（NYSE:MRK - 获取免费报告）上一次发布季度财报是在 2 月 4 日，报告显示该季度每股收益为 1.72 美元，低于市场共识预期的 1.85 美元（差 0.13 美元）。该季度的收入为 156.2 亿美元，而分析师预期为 155.1 亿美元。默克公司的股本回报率为 45.35%，净利润率为 26.67%。该公司的收入同比增长 6.8%。去年同期，该公司每股收益为 0.03 美元。分析师预计默克公司今年每股收益将达到 9.01 美元。</p>
</div><ul>
<li>Moderna Shares Spike on H5N1 News—What’s Next for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>Moderna 股价因 H5N1 新闻飙升——投资者接下来该怎么办？</li>
</ul>
</div><p>Merck &amp; Co., Inc. announced that its board has authorized a share repurchase program on Tuesday, January 28th that authorizes the company to buyback $10.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 4.1% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>默克公司宣布其董事会于 1 月 28 日授权了一项股票回购计划，授权公司回购 100 亿美元的流通股。该回购授权允许公司通过公开市场购买最多 4.1% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>Merck &amp; Co., Inc. Dividend Announcement</h2>
<div class="lb-trans"><h2>默克公司分红公告</h2>
</div><p>The firm also recently declared a quarterly dividend, which will be paid on Monday, April 7th. Investors of record on Monday, March 17th will be issued a $0.81 dividend. This represents a $3.24 dividend on an annualized basis and a yield of 3.84%. The ex-dividend date is Monday, March 17th. Merck &amp; Co., Inc.'s dividend payout ratio (DPR) is 48.14%.</p>
<div class="lb-trans"><p>该公司最近宣布了一项季度分红，将于 4 月 7 日支付。3 月 17 日的登记投资者将获得 0.81 美元的分红。这相当于年化 3.24 美元的分红，收益率为 3.84%。除息日为 3 月 17 日。默克公司的分红支付比率（DPR）为 48.14%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>MarketBeat Week in Review – 11/4 - 11/8</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 11/4 - 11/8</li>
</ul>
</div><p>Several research analysts have recently weighed in on the stock. Daiwa America cut shares of Merck &amp; Co., Inc. from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Monday, November 11th. TD Securities lowered Merck &amp; Co., Inc. from a &#34;buy&#34; rating to a &#34;hold&#34; rating and cut their price target for the company from $121.00 to $100.00 in a report on Monday. UBS Group decreased their price objective on Merck &amp; Co., Inc. from $125.00 to $120.00 and set a &#34;buy&#34; rating on the stock in a research note on Wednesday, January 8th. Morgan Stanley cut their price objective on Merck &amp; Co., Inc. from $113.00 to $106.00 and set an &#34;equal weight&#34; rating for the company in a research note on Wednesday, February 5th. Finally, BMO Capital Markets reduced their target price on shares of Merck &amp; Co., Inc. from $105.00 to $96.00 and set a &#34;market perform&#34; rating for the company in a report on Wednesday, February 5th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, nine have given a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, Merck &amp; Co., Inc. presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $117.06.</p>
<div class="lb-trans"><p>几位研究分析师最近对该股票发表了看法。大和证券在 11 月 11 日的研究报告中将默克公司的股票评级从 “强力买入” 下调至 “持有”。TD 证券将默克公司的评级从 “买入” 下调至 “持有”，并将其目标价从 121.00 美元下调至 100.00 美元。瑞银集团在 1 月 8 日的研究报告中将默克公司的目标价从 125.00 美元下调至 120.00 美元，并对该股票给予 “买入” 评级。摩根士丹利在 2 月 5 日的研究报告中将默克公司的目标价从 113.00 美元下调至 106.00 美元，并对该公司给予 “同等权重” 评级。最后，BMO 资本市场在 2 月 5 日的报告中将默克公司的目标价从 105.00 美元下调至 96.00 美元，并对该公司给予 “市场表现” 评级。一位股票研究分析师对该股票给予了卖出评级，十位分析师给予了持有评级，九位给予了买入评级，三位给予了强力买入评级。根据 MarketBeat 的数据，默克公司目前的共识评级为 “适度买入”，平均目标价为 117.06 美元。</p>
</div><p><strong>View Our Latest Report on MRK</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 MRK 的最新报告</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other news, Director Inge G. Thulin bought 2,833 shares of the firm's stock in a transaction on Thursday, February 6th. The stock was acquired at an average cost of $88.25 per share, with a total value of $250,012.25. Following the completion of the acquisition, the director now owns 2,933 shares of the company's stock, valued at approximately $258,837.25. This represents a 2,833.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Also, insider Cristal N. Downing sold 2,361 shares of the company's stock in a transaction that occurred on Thursday, February 6th. The shares were sold at an average price of $88.76, for a total value of $209,562.36. Following the completion of the transaction, the insider now directly owns 7,085 shares in the company, valued at $628,864.60. This trade represents a 24.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.09% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，董事 Inge G. Thulin 于 2 月 6 日的交易中购买了 2,833 股公司的股票。该股票的平均购买成本为每股 88.25 美元，总价值为 250,012.25 美元。收购完成后，该董事现在拥有 2,933 股公司的股票，价值约为 258,837.25 美元。这代表其持股增加了 2,833.00%。该交易已在证券交易委员会的法律文件中披露，可以通过 SEC 网站访问。此外，内部人士 Cristal N. Downing 在 2 月 6 日的交易中出售了 2,361 股公司的股票。该股票的平均售价为 88.76 美元，总价值为 209,562.36 美元。交易完成后，该内部人士现在直接拥有 7,085 股公司股票，价值为 628,864.60 美元。该交易代表其持股减少了 24.99%。该销售的披露信息可以在此找到。公司内部人士持有公司股票的 0.09%。</p>
</div><h2>Institutional Investors Weigh In On Merck &amp; Co., Inc.</h2>
<div class="lb-trans"><h2>机构投资者对默克公司的看法</h2>
</div><p>A number of institutional investors and hedge funds have recently bought and sold shares of the stock. E&amp;G Advisors LP raised its position in Merck &amp; Co., Inc. by 0.7% in the 3rd quarter. E&amp;G Advisors LP now owns 14,698 shares of the company's stock valued at $1,669,000 after purchasing an additional 100 shares during the last quarter. Massachusetts Wealth Management increased its stake in Merck &amp; Co., Inc. by 0.4% in the third quarter. Massachusetts Wealth Management now owns 22,474 shares of the company's stock valued at $2,552,000 after purchasing an additional 100 shares during the period. Shayne &amp; Jacobs LLC raised its holdings in shares of Merck &amp; Co., Inc. by 1.8% in the third quarter. Shayne &amp; Jacobs LLC now owns 5,611 shares of the company's stock valued at $637,000 after buying an additional 100 shares during the last quarter. Alan B Lancz &amp; Associates Inc. boosted its stake in shares of Merck &amp; Co., Inc. by 0.7% during the third quarter. Alan B Lancz &amp; Associates Inc. now owns 13,834 shares of the company's stock worth $1,571,000 after buying an additional 100 shares during the period. Finally, First Bank &amp; Trust boosted its stake in shares of Merck &amp; Co., Inc. by 1.1% during the third quarter. First Bank &amp; Trust now owns 8,995 shares of the company's stock worth $1,021,000 after buying an additional 101 shares during the period. 76.07% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>最近，一些机构投资者和对冲基金买卖了该股票的股份。E&amp;G Advisors LP 在第三季度将其在默克公司的持股比例提高了 0.7%。E&amp;G Advisors LP 现在拥有 14,698 股该公司的股票，价值 1,669,000 美元，此前在上个季度又购买了 100 股。马萨诸塞州财富管理公司在第三季度将其在默克公司的股份增加了 0.4%。马萨诸塞州财富管理公司现在拥有 22,474 股该公司的股票，价值 2,552,000 美元，此前在此期间又购买了 100 股。Shayne &amp; Jacobs LLC 在第三季度将其在默克公司的持股提高了 1.8%。Shayne &amp; Jacobs LLC 现在拥有 5,611 股该公司的股票，价值 637,000 美元，此前在上个季度又购买了 100 股。Alan B Lancz &amp; Associates Inc.在第三季度将其在默克公司的股份提高了 0.7%。Alan B Lancz &amp; Associates Inc.现在拥有 13,834 股该公司的股票，价值 1,571,000 美元，此前在此期间又购买了 100 股。最后，First Bank &amp; Trust 在第三季度将其在默克公司的股份提高了 1.1%。First Bank &amp; Trust 现在拥有 8,995 股该公司的股票，价值 1,021,000 美元，此前在此期间又购买了 101 股。76.07% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Merck &amp; Co., Inc. Company Profile</h2>
<div class="lb-trans"><h2>默克公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Merck &amp; Co, Inc is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.</p>
<div class="lb-trans"><p>默克公司是一家医疗保健公司，提供通过处方药、疫苗、生物治疗、动物健康和消费者护理产品的健康解决方案。它通过以下几个部门运营：制药、动物健康和其他。制药部门包括人类健康药品和疫苗产品。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Merck &amp; Co., Inc.</li>
<li>Learn Technical Analysis Skills to Master the Stock Market</li>
<li>Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up</li>
<li>What Investors Need to Know to Beat the Market</li>
<li>Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>Buffett Buys More Occidental Petroleum—Sticking to His Playbook</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过默克公司。</li>
<li>学习技术分析技能，掌握股市。</li>
<li>Upstart 的上升趋势刚刚开始：是时候加仓了。</li>
<li>投资者需要知道的击败市场的信息。</li>
<li>Archer Aviation 获得黑石投资——ACHR 的下一步是什么？</li>
<li>如何投资蓝筹股。</li>
<li>巴菲特增持西方石油——坚持他的投资策略。</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Where Should You Invest $1,000 Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 吗？</h2>
</div><p>Before you make your next trade, you'll want to hear this.</p>
<div class="lb-trans"><p>在你进行下一笔交易之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。</p>
</div><p>Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.</p>
<div class="lb-trans"><p>我们的团队已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而且没有一只大名鼎鼎的股票在名单上。</p>
</div><p>They believe these five stocks are the five best companies for investors to buy now...</p>
<div class="lb-trans"><p>他们认为这五只股票是投资者现在应该购买的五家最佳公司……</p>
</div><p>See The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div><h2>Should You Invest $1,000 in Merck &amp; Co., Inc. Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在默克公司吗？</h2>
</div><p>Before you consider Merck &amp; Co., Inc., you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑默克公司之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck &amp; Co., Inc. wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而默克公司不在名单上。</p>
</div><p>While Merck &amp; Co., Inc. currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然默克公司目前在分析师中有 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

交易员大量买入默克公司（纽约证券交易所代码：MRK）的看跌期权